Julian S Gangolli Krystal Biotech, Inc. (KRYS) insider trading activity

Julian S Gangolli is Director of Krystal Biotech, Inc.. Currently has a direct ownership of 0 shares of KRYS, which is worth approximately $0. The most recent transaction as insider was on May 20, 2024, when has been sold 20,000 shares (Common Stock) at a price of $164.6 per share, resulting in proceeds of $3,292,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Julian S Gangolli Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 20 2024	SELL Open market or private sale	$3,292,000 $164.6 p/Share	20,000 Reduced 100.0%	0 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$455,000 $22.75 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

OTLK

Outlook Therapeutics, Inc. Healthcare

RVNC

Revance Therapeutics, Inc. Healthcare

Director

JSG